RGC
Regencell Bioscience Holdings Ltd
4.90$
-3.6%
vs. previous close
Closing price · As of: Nov 13, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | – | – | |
| 3.7% | 38.6% | 38.4% | 3.9% | – | – | – | – | – | – | – | – | |
| 96.3% | 61.4% | 61.6% | 96.1% | – | – | – | – | – | – | – | – | |
| 2.5% | 16.0% | 16.0% | 2.7% | – | – | – | – | – | – | – | – | |
| 39.9% | 50.5% | 50.9% | 41.4% | – | – | – | – | – | – | – | – | |
| 10.2% | 10.8% | 10.8% | 8.6% | – | – | – | – | – | – | – | – | |
| – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 6.0% | 8.1% | 8.8% | 6.8% | – | – | – | – | – | – | – | – | |
| 2.5% | 3.2% | 3.5% | 3.2% | – | – | – | – | – | – | – | – | |
| 3.5% | 4.9% | 5.3% | 3.6% | – | – | – | – | – | – | – | – | |
| 13.1% | 15.0% | 16.0% | 14.8% | – | – | – | – | – | – | – | – |
Data as of: November 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.